Literature DB >> 4593674

The effect of alprenolol in combination with hydralazine in essential hypertension. A double-blind, crossover study and a long-term follow-up study.

J Pape.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4593674     DOI： 10.1111/j.0954-6820.1974.tb02514.x

Source DB:  PubMed          Journal:  Acta Med Scand Suppl        ISSN： 0365-463X


× No keyword cloud information.
  5 in total

1.  Clinical pharmacokinetics of hydrallazine.

Authors:  T Talseth
Journal:  Clin Pharmacokinet       Date:  1977 Sep-Oct       Impact factor: 6.447

2.  A controlled study on the antihypertensive effect of a new beta-adrenergic receptor blocking drug, metoprolol, in combination with chlorthalidone.

Authors:  A Jäättelä; K Pyörälä
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

3.  Dependence of the cardiovascular effects of pindolol on the individual sympathetic nervous activity.

Authors:  N Tanaka; K Kawahira; A Kudo; T Kashima; H Tanaka
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 4.  Drug-induced sexual dysfunction.

Authors:  D E McWaine; W R Procci
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Jul-Aug

5.  Hypotensive effect of oxprenolol in mild to moderate hypertension: a multicentre controlled study.

Authors:  M Motolese; G Muiesan; A Colombi
Journal:  Eur J Clin Pharmacol       Date:  1975       Impact factor: 2.953
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.